Role of cholesterol crystallization-promoting protein in the pathogenesis of cholesterol gallstone.
Role of cholesterol crystallization-promoting protein in the pathogenesis of cholesterol gallstone.
批准号:
05670445
负责人:
TANAKA Naomi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
胆汁中胆固醇快速结晶是导致胆固醇胆结石形成的关键事件。最近报道了胆结石胆汁中存在几种胆固醇结晶的糖蛋白促进剂(免疫球蛋白、磷脂酶C、氨肽酶N),引起了全世界的关注。我们成功分离出一个新的启动子,并将其鉴定为α_1-酸性糖蛋白。然而,没有研究在体外比较这些启动子,它们在胆结石发病机制中的确切作用仍然未知。因此,我们的研究目的是阐明这些胆固醇结晶促进剂在胆结石发病机制中的作用。首先,在体外比较了这些糖蛋白的胆固醇结晶促进活性。结果发现,只有α_1-酸性糖蛋白和免疫球蛋白在胆汁中的生理水平上发挥促进活性。其次,采用新建立的特异性ELISA法测定不同胆结石和非胆结石患者胆汁中α_1酸性糖蛋白的水平,并与胆汁中胆固醇成核时间进行比较。这表明,在具有单一胆固醇或胆色素结石的胆汁中,α_1-酸性糖蛋白水平没有改变,但在具有多个胆固醇胆结石的胆汁中,α_1-酸性糖蛋白水平特别升高,并且其增加与快速成核时间相关。体外有效的促进活性以及多发性胆固醇胆结石时胆汁(体内)的特异性增加表明胆汁α_1-酸性糖蛋白在多发性胆固醇胆结石形成中的关键作用。
英文摘要
Rapid cholesterol crystallization in bile is the critical event leading to cholesterol gallstone formation. Several glycoprotein promoters (immunoglobulins, phospholipase C,aminopeptidase N) of cholesterol crystallization have recently been reported in bile with gallstones, which have received world-wide attention. We have successfully isolated a new promoter and identified it as alpha_1-acid glycoprotein. However, no study compared these promoters in vitro and their precise role in the pathogenesis of gallstones remains unknown. Therefore, we aimed in this study to clarify the role of these cholesterol crystallization-promoters in the pathogenesis of gallstones. Firstly, the cholesterol crystallization-promoting activity of these glycoproteins was compared in vitro. It was found that only alpha_1-acid glycoprotein and immunoglobulins exsert the promoting activity at their physiologic levels in bile. Secondly, the biliary levels of alpha_1-acid glycoprotein in various gallstone and non-gallstone patients were assayd by a newly established specific ELISA and compared with the cholesterol nucleation time in bile. This revealed that the alpha_1-acid glycoprotein level is not altered in biles with solitary cholesterol or pigment gallstones but it is specifically elevated in biles with multiple cholesterol gallstones and that its increase is associated with rapid nucleation time. The potent promoting activity in vitro as well as the specific increase in bile (in vivo) with multiple cholesterol gallstones suggest the critical role of the biliary alpha_1-acid glycoprotein in the formation of multiple cholesterol gallstones.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Abei Masato: "Identification of human biliary α_1-acid glycoprotein as a cholesterol crystallization promoter" Gastroenterology. 106. 231-238 (1994)
阿贝正人:“鉴定人胆汁α_1-酸性糖蛋白作为胆固醇结晶促进剂”胃肠病学106。231-238(1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
田中直見: "胆石症" 300症患診療マニュアル,中井利昭編,中外医学社. 172-173 (1993)
田中直美:《胆石症》300例患者治疗手册,中井俊明主编,中外医学社172-173(1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Abei Masato: "Isolation and characterization of a cholesterol crystallization promotor from human bile" Gastroenterology. 104. 539-548 (1993)
阿贝正人:“从人胆汁中分离和表征胆固醇结晶促进剂”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
安倍井 誠人: "ヒト 胆汁中コレステロール結晶形成促進蛋白の解析(精製同定、定量)とそのコレステロール胆石形成における意義" 薬理と治療. 23. S693-S698 (1995)
Makoto Abei:“人胆汁中胆固醇晶体形成促进蛋白的分析(纯化鉴定、定量测定)及其在胆固醇胆结石形成中的意义”23.S693-S698(1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
田中 直見: "消化器診療プラクティス(4)胆嚢疾患" 文光堂, (1993)
田中直美:《消化道临床实践(4)胆囊疾病》文科堂(1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Experimental Analysis and Application of Cancer-selectively Replicating Adenovirus for Gene Therapy of Gallbladder Cancer.
-
批准号:14370174
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:2002
-
负责人:TANAKA Naomi
-
依托单位:
Mechanism of anti-proliferation effects of dehydroepiandrosterone on colon cancer
-
批准号:10470130
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.03万
-
财政年份:1998
-
负责人:TANAKA Naomi
-
依托单位:
The immunopathogenesis and the regulation of hepatic lesions in murine model of primary biliary cirrhosis.
-
批准号:08457160
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1996
-
负责人:TANAKA Naomi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
-
批准号:82371192
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田婕
-
依托单位:
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
-
批准号:82072798
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张丽
-
依托单位:
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
-
批准号:81302714
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:俞媛
-
依托单位: